Location History:
- Menlo Park, CA (US) (2019 - 2020)
- Mountain View, CA (US) (2021 - 2023)
Company Filing History:
7 out of 5,309 
2 out of 144 
2 out of 298 
Years Active: 2019-2023
Title: Christopher Barry Locke: Innovating Radiotherapy Solutions
Introduction
Christopher Barry Locke is an accomplished inventor located in Mountain View, CA, with an impressive portfolio of seven patents. His work focuses primarily on optimizing radiotherapy treatment planning, facilitating improved cancer care through innovative techniques.
Latest Patents
Among his latest inventions, Locke has developed methods for incorporating multiple targets in trajectory optimization for radiotherapy treatment planning. This process involves determining beam's eye view (BEV) regions and a BEV region connectivity manifold for each target group separately. The data derived from the BEV regions helps guide an optimizer to discover optimal treatment trajectories. Additionally, a post-processing step may enhance insufficiently exposed voxels of planning target volumes (PTVs) by enlarging specific BEV regions during treatment optimization.
Another significant patent by Locke focuses on beam angle optimization for external beam radiation therapy using sectioning. This method evaluates the dose response of various regions of interest in a delivery coordinate space (DCS) to optimize field geometries in intensity-modulated radiotherapy (IMRT) treatment. Like in his other patents, this approach also incorporates a post-processing step to improve visibility for certain PTVs.
Career Highlights
Christopher Barry Locke has significantly impacted the medical field through his inventive solutions. He has worked for notable institutions such as Leland Stanford Junior University and Varian Medical Systems International AG. His expertise in radiotherapy has positioned him as a respected figure in the realm of cancer treatment innovation.
Collaborations
Throughout his career, Locke has collaborated with professionals including Karl Kenneth Bush and Santtu Ollila. These partnerships have contributed to the development of his groundbreaking patents, enabling advancements in the methods and technologies used in radiotherapy.
Conclusion
Christopher Barry Locke's work stands as a testament to the power of innovation in the medical field. His seven patents reflect not only his dedication to improving radiotherapy outcomes but also his role in fostering collaboration to enhance cancer treatment methodologies. His contributions are paving the way for future advancements in the healthcare industry.